Skin Cancer Screenings Should Follow Same Timeline for Non-White, White SOTRs
Background: Solid organ transplant recipients (SOTRs) are at an increased risk of developing cutaneous malignancies, particularly squamous cell carcinomas (SCCs), which tend to exhibit aggressive features. While white race has been found to be an important risk factor in the development of keratinocyte carcinomas in post-transplant patients, the temporality of developing these carcinomas is not well understood. Objective: To evaluate the timing of skin cancer development in patients undergoing transplant based on racial differences. Design/Methods: Retrospective cohort study conducted with a diverse cohort of SOTR patients from the Mount Sinai Health System. Results: 10,767 SOTRs were identified with 3715 being white and 7052 being non-white (Hispanic, black, Asian, or other). The incidence of SCC and basal cell carcinoma (BCC) was increased in white patients at 5.14% and 5.22%, respectively, compared to non-white patients who had an SCC incidence of 0.808% and BCC incidence of 0.496
more...
Want to read the full article?
To view, you must be an active Practical Reviews subscriber.